Bryan Smith was Appointed as General Counsel at Urovant

Date of management change: June 28, 2018 

What Happened?

Irvine, -based Urovant Appointed Bryan Smith as General Counsel


About the Company

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions. Urovant`s lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist being developed for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. We have initiated an international Phase 3 program for vibegron. We also intend to expand our pipeline in urologic diseases in the future.


About the Person

Bryan Smith is General Counsel at Urovant. Previously, Bryan held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Harman Jason, Strick Wheatley Christine, Fatovic Robert, Mishal Shelly, Szoke Jamie, Utter Cynthia, Planchard Steven, Zucker Jody, Novak Abby, Kremmel Donn, Mort Susan

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.